Phase II Randomized Study of Salvage Radiation Therapy (SRT) plus Enzalutamide or Blinded Placebo for High-Risk PSA-Recurrent Prostate Cancer after Radical Prostatectomy: The SALV-ENZA Trial
Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: University of Maryland, Baltimore, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Oregon Health & Science University, University of Michigan, Wayne State University, Indiana University Health, University of Chicago Medical Center, The Barbara Ann Karmanos Cancer Institute, The University of Texas Southwestern Medical Center, University Hospitals Seidman Cancer Center, Case Western Reserve University, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of Minnesota
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4307291340